A new kind of single-dose vaccine that comes in a nasal spray and doesn’t require refrigeration could dramatically alter the public health landscape -- get more people vaccinated around the world and address the looming threats of emerging and re-emerging diseases. Researchers presented the latest design and testing of these “nanovaccines” at the 247th National Meeting & Exposition of the American Chemical Society (ACS) in Dallas this week.
Hey, check out all the research scientist jobs. Post your resume today!
